SCOPUS 정보 검색 플랫폼

Volumn 41, Issue 2, 1988, Pages 315-322

Eradication of mouse melanoma by combined treatment with recombinant human interleukin 2 and recombinant murine interferon‐gamma

(3) Silagi, Selma a Dutkowski, Regina a Schaefer, Annette b

a WEILL CORNELL MEDICAL COLLEGE (United States)

b CITY UNIVERSITY OF NEW YORK (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 2;

ANIMAL EXPERIMENT; ANIMAL MODEL; CONTROLLED STUDY; FEMALE; INTRAPERITONEAL DRUG ADMINISTRATION; MELANOMA B16; MOUSE; NONHUMAN; SUBCUTANEOUS DRUG ADMINISTRATION;

ANIMAL; CELL DIVISION; DRUG SYNERGISM; DRUG THERAPY, COMBINATION; FEMALE; IMMUNOTHERAPY; INTERFERON TYPE II; INTERLEUKIN-2; LEUKOCYTES, MONONUCLEAR; MELANOMA, EXPERIMENTAL; MICE; MICE, INBRED C57BL; NEOPLASM TRANSPLANTATION; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0023911154 PISSN: 00207136 EISSN: 10970215 Source Type: Journal
DOI: 10.1002/ijc.2910410225 Document Type: Article

Times cited : (38)

References (30)

1
- 0023582272
- Gamma‐interferon: physiology and speculation on its role in medicine
- (1987) J. biol. Resp. Modif. , vol.6 , pp. 275-301
- Bonnem, E.M.¹ Oldham, R.K.²

2
- 0019751559
- Interferons: biochemical, cell growth inhibitory, and immunological effects
- E. B. Brown, Grune and Stratton, New York
- (1981) Progress in hematology , vol.12 , pp. 299-339
- Borden, E.C.¹ Ball, L.A.²

3
- 0022470454
- Interaction of recombinant interferons with recombinant interleukin‐2: differential effects on natural killer cell activity and interleukin‐2 activated killer cells
- (1986) Inst J. Cancer , vol.37 , pp. 787-793
- Brunda, M.J.¹ Tarnowski, D.² Davatelis, V.³

4
- 0021922105
- Tumour inhibitory effects of TCGF/IL‐2/‐containing preparations
- (1985) Cancer Immunology Immunotherapy , vol.19 , pp. 57-61
- Bubenik, J.¹ Indrova, M.² Perlmann, P.³ Berzins, K.⁴ Mach, O.⁵ Kraml, J.⁶ Toulcova, A.⁷

5
- 85012627448
- Leukocyte subpopulations elicited by a nontumorigenic variant of B16 melanoma: their role in direct rejection of the melanoma and in prevention of tumorigenesisin Winn assays
- (1982) J. exp. Med. , vol.156 , pp. 1723-1738
- Calvelli, T.A.¹ Freedman, V.H.² Silverstein, S.C.³ Silagi, S.⁴

6
- 0018883709
- Macrophages elicited with heat‐killed bacillus Calmette‐Guerin protect C57BL/6 mice against a syngeneic melanoma
- (1980) J. exp. Med. , vol.152 , pp. 657-671
- Freedman, V.H.¹ Calvelli, T.A.² Silagi, S.³ Silverstein, S.C.⁴

7
- 0022922289
- Interferon therapy in cancer: from imaginon to interferon
- (1986) Cancer Res. , vol.46 , pp. 4315-4329
- Goldstein, D.¹ Lazlo, J.²

8
- 0021826670
- Therapy of disseminated murine leukemia with cyclophosphamide and immune Lyt‐1+, 2‐T cells
- (1985) J. exp. Med. , vol.161 , pp. 1122-1134
- Greenberg, P.D.¹ Kern, D.E.² Cheever, M.A.³

9
- 0022355003
- Generation of activated killer (AK) cells by recombinant interleukin 2 (rIL‐2) in collaboration with interferon‐γ (IFN‐γ)
- (1985) J. Immunol. , vol.134 , pp. 3124-3129
- Itoh, K.¹ Shiiha, K.² Shimizu, Y.³ Suzuki, R.⁴ Kumagai, K.⁵

10
- 0020576411
- Interleukin‐2 induces γ‐interferon production: participation of macrophages and NK‐like cells
- (1983) J. Immunol. , vol.131 , pp. 288-292
- Kawase, I.¹ Brooks, C.G.² Kuribayashi, K.³ Olabuenaga, S.⁴ Newman, W.⁵ Gillis, S.⁶ Henney, C.S.⁷

11
- 0021135378
- Immunotherapy of murine and human tumors in mice with lymphokines and interleukin‐2‐propagated lymphocytes
- (1984) J. biol. Resp. Modif. , vol.3 , pp. 517-526
- Kedar, E.¹ Chriqui‐Zeira, E.² Kyriazis, A.P.³

12
- 0022493572
- Activation or suppression of the tumoricidal properties of monocytes from cancers patients following treatment with human recombination γ‐interferon
- (1986) Cancer Res. , vol.46 , pp. 5401-5405
- Kleinerman, E.S.¹ Kurzrock, R.² Wyatt, D.³ Quesada, J.R.⁴ Gutterman, J.U.⁵ Fidler, I.J.⁶

13
- 0019862911
- Murine NK cell culture: effects of interleukin‐2 and interferon on cell growth and cytotoxic reactivity
- (1986) J. Immunol. , vol.126 , pp. 2321-2327
- Kuribayashi, K.¹ Gillis, S.² Kern, E.³ Henney, C.S.⁴

14
- 84944285022
- High‐dose recombinant interleukin 2 in the treatment of patients with disseminated cancer
- (1986) J. Amer med. Ass. , vol.25 , pp. 3117-3124
- Lotze, M.T.¹ Chang, A.E.² Seipp, C.A.³ Simpson, C.⁴ Vetto, J.T.⁵ Rosenberg, S.A.⁶

15
- 0020047427
- Cyclophosphamide‐facilitated adoptive immunotherapy of an established tumor depends on elimination of tumor‐induced suppressor T cells
- (1982) J. exp. Med. , vol.55 , pp. 1063-1074
- North, R.J.¹

16
- 0021235831
- Effects of natural and recombinant IL 2 on regulation of IFN‐γ production and natural killer activity: lack of involvement of the TAC antigen for these immunoregulatory effects
- (1984) J. Immunol. , vol.133 , pp. 779-783
- Ortaldo, J.R.¹ Mason, A.T.² Gerard, J.P.³ Henderson, L.E.⁴ Farrar, W.⁵ Hopkins, R.F.⁶ Herberman, R.B.⁷ Rabin, H.⁸

17
- 0023110684
- Immunotherapy of intraperitoneal cancer with interleukin 2 and lymphokine‐activated killer cells reduces tumor load and prolongs survival in murine models
- (1987) Cell Immunol. , vol.104 , pp. 366-376
- Ottow, R.T.¹ Steller, E.P.² Sugarbaker, P.H.³ Wesley, R.A.⁴ Rosenberg, S.A.⁵

18
- 0022467674
- Antitumor efficacy of lymphokine‐activated killer cells and recombinant interleukin 2 in vivo: successful immunotherapy of established pulmonary metastases from weakly immunogenic and nonimmunogenic murine tumors of three distinct histological types
- (1986) Cancer Res. , vol.46 , pp. 4973-4978
- Papa, M.Z.¹ Mule, J.J.² Rosenberg, S.A.³

19
- 0022510365
- Generation of mouse natural killer (NK) cell activity: effect of interleukin‐2 (IL‐2) and interferon (IFN) on the in vivo development of natural killer cells from bone marrow (BM) progenitor cells
- (1986) Int. J. Cancer , vol.38 , pp. 553-562
- Riccardi, C.¹ Giampietri, A.² Migliorati, G.³ Cannarile, L.⁴ D'Adamio, L.⁵ Herberman, R.B.⁶

20
- 0022349817
- Observations on the systemic administration of autologous lymphokine‐activated killer cells and recombinant interleukin‐2 to patients with metastatic cancer
- (1985) N. Engl. J. Med. , vol.313 , pp. 1485-1492
- Rosenberg, S.A.¹ Lotze, M.T.² Muul, L.M.³ Leitman, S.⁴ Chang, A.E.⁵ Ettinghausen, S.E.⁶ Matory, Y.L.⁷ Skibber, J.M.⁸ Shiloni, E.⁹ Vetto, J.T.¹⁰ Seipp, C.A.¹¹ Simpson, C.¹² Reichart, C.M.¹³

21
- 0022473607
- (1986) A new approach to the adoptive immunotherapy of cancer with tumor‐infiltrating lymphocytes, Science , vol.233 , pp. 1318-1321
- Rosenberg, S.A.¹ Spiess, P.² Lafreniere, R.³

22
- 0022534622
- Extravasation of intravascular fluid mediated by the systemic administration of recombinant interleukin 2
- (1986) J. Immunol. , vol.137 , pp. 1735-1742
- Rosenstein, M.¹ Ettinghausen, S.E.² Rosenberg, S.A.³

23
- 0016426055
- A simple cytochemical technique for demonstration of DNA in cells infected with mycoplasma and viruses
- (1975) Nature (Lond.) , vol.253 , pp. 461-462
- Russell, W.C.¹ Newman, C.² Williamson, D.H.³

24
- 0022394512
- In vivo augmentation of natural killer activity by combined treatment with recombinant gamma interferon and interleukin‐2
- (1985) J. Interferon Res. , vol.5 , pp. 571-581
- Shalaby, M.R.¹ Svedersky, L.P.² McKay, P.A.³ Finkle, B.S.⁴ Palladino, M.A.⁵

25
- 0014610442
- Control of pigment production in mouse melanoma cells. in vitro
- (1969) J. Cell Biol. , vol.43 , pp. 263-274
- Silagi, S.¹

26
- 0017101226
- Effects of 5‐bromodeoxyuridine on tumorigenicity, immunogenicity, virus production, plasminogen activator and melanogenesis of mouse melanoma cells
- (1976) Int. Rev. Cytol. , vol.45 , pp. 65-111
- Silagi, S.¹

27
- 0022968105
- Successful immunotherapy of mouse melanoma and sarcoma with recombinant interleukin‐2 and cyclophosphamide
- (1986) J. biol. Resp. Modif. , vol.5 , pp. 411-422
- Silagi, S.¹ Schaefer, A.E.²

28
- 0023222396
- Influence of the administration schedule on the therapeutic effect of interleukin‐2
- (1987) Int. J. Cancer , vol.39 , pp. 530-533
- Vaage, J.¹ Pauly, J.L.² Harlos, J.P.³

29
- 0022572638
- + clones
- (1986) J. Immunol. , vol.136 , pp. 1700-1707
- van de Griend, R.J.¹ Ronteltap, C.P.M.² Gravekamp, C.³ Bolhuis, R.L.H.⁴

30
- 0020601412
- Interleukin‐2 enhances natural killer cell activity through induction of gamma interferon
- (1983) Infect. Immun. , vol.41 , pp. 992-997
- Weigent, D.A.¹ Stanton, G.J.² Johnson, H.M.³

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.